Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2084668

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2084668

Balloon Valvuloplasty Device Market, By Type, By Type of Valvuloplasty, By Indication, By End User, By Geography

PUBLISHED:
PAGES: 250 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4500
PDF & Excel (Multi User License - Up to 7 Users)
USD 7000
PDF & Excel (Corporate User License)
USD 10000

Add to Cart

Balloon Valvuloplasty Device Market is estimated to be valued at USD 1,050.4 Mn in 2026 and is expected to reach USD 2,203.2 Mn by 2033, growing at a compound annual growth rate (CAGR) of 11.2% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 1,050.4 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 11.20% 2033 Value Projection: USD 2,203.2 Mn

Balloon valvuloplasty devices are minimally invasive devices delivered via a catheter to dilate stenotic heart valves in the population with valvular stenosis. These devices are a fundamental part of interventional cardiology as they open blocked valves and enhance blood flow through the valve, ameliorating symptoms in patients with diseases affecting aortic, mitral, or pulmonary valves.

The market for balloon valvuloplasty devices is primarily being boosted by a rising rate of cardiovascular diseases and valvular heart disorders worldwide and by a growing aged population throughout the world. Growing popularity for minimally invasive cardiac procedures, evolution of catheter and balloon technology, and expanded availability of advanced cardiac care centers contribute to a rise in the balloon valvuloplasty device market. Future growth prospects are anticipated, due to the ongoing development of health care infrastructure and increasing use of transcatheter heart valve procedures.

Market Dynamics

The global balloon valvuloplasty device market is driven by the increasing prevalence of valvular heart diseases, rising burden of cardiovascular diseases and growing geriatric population susceptible to valve stenosis. Besides these, increasing adoption of minimally invasive cardiac procedures, growing advancement of catheter-based techniques, widespread availability of cardiac specialized care centers are some of the other factors contributing to the growth of the balloon valvuloplasty device market. Advanced diagnostic capabilities and increasing awareness towards early treatment of structural heart diseases are also contributing to market growth.

However, the growth of the balloon valvuloplasty device market is limited by factors such as increasing costs of interventional cardiac procedures, risks of balloon valvuloplasty procedures like restenosis, and stringency of regulations over cardiovascular devices are few factors restraining market growth. Limited accessibility to modern cardiac treatments in low-income countries might also impact the market growth. Nevertheless, there are abundant growth prospects due to factors such as growing development of balloon catheter designs, growing healthcare expenditure by emerging countries, increasing use of transcatheter heart valve therapies, focus towards enhanced patient outcomes through less invasive treatments will bring huge growth opportunities for the balloon valvuloplasty device market in the coming years.

Key Features of the Study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global balloon valvuloplasty device market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Edwards Lifesciences Corporation, Boston Scientific Corporation, Medtronic plc, B. Braun SE, NuMED Inc., Balton Sp. z o.o., Cook Medical, Cardinal Health, Osypka AG, and Braile Biomedica
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global balloon valvuloplasty device market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global balloon valvuloplasty device market

Market Segmentation

  • Type Insights (Revenue, USD Mn, 2021 - 2033)
  • 20 mm
  • 23 mm
  • 26 mm
  • 29 mm
  • Others
  • Type of Valvuloplasty Insights (Revenue, USD Mn, 2021 - 2033)
  • Percutaneous Balloon Mitral Valvuloplasty
  • Percutaneous Balloon Pulmonary Valvuloplasty
  • Percutaneous Balloon Tricuspid Valvuloplasty
  • Percutaneous Balloon Aortic Valvuloplasty
  • Indication Insights (Revenue, USD Mn, 2021 - 2033)
  • Aortic Valve Stenosis
  • Pulmonary Valve Stenosis
  • Mitral Valve Stenosis
  • Tricuspid Valve Stenosis
  • End User Insights (Revenue, USD Mn, 2021 - 2033)
  • Hospitals
  • Ambulatory Surgery Centers
  • Others
  • Regional Insights (Revenue, USD Mn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
  • Edwards Lifesciences Corporation
  • Boston Scientific Corporation
  • Medtronic plc
  • Braun SE
  • NuMED Inc.
  • Balton Sp. z o.o.
  • Cook Medical
  • Cardinal Health
  • Osypka AG
  • Braile Biomedica
Product Code: CMI9621

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Balloon Valvuloplasty Device Market, By Type
    • Global Balloon Valvuloplasty Device Market, By Type of Valvuloplasty
    • Global Balloon Valvuloplasty Device Market, By Indication
    • Global Balloon Valvuloplasty Device Market, By End User
    • Global Balloon Valvuloplasty Device Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Market Opportunities
  • Regulatory Scenario
  • Industry Trends

4. Global Balloon Valvuloplasty Device Market, By Type, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • 20 mm
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • 23 mm
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • 26 mm
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • 29 mm
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global Balloon Valvuloplasty Device Market, By Type of Valvuloplasty, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Percutaneous Balloon Mitral Valvuloplasty
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Percutaneous Balloon Pulmonary Valvuloplasty
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Percutaneous Balloon Tricuspid Valvuloplasty
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Percutaneous Balloon Aortic Valvuloplasty
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global Balloon Valvuloplasty Device Market, By Indication, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Aortic Valve Stenosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Pulmonary Valve Stenosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Mitral Valve Stenosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Tricuspid Valve Stenosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

7. Global Balloon Valvuloplasty Device Market, By End User, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Ambulatory Surgery Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

8. Global Balloon Valvuloplasty Device Market, By Region, 2021 - 2033, Value (USD Mn)

  • Introduction
    • Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
    • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Type of Valvuloplasty, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Type of Valvuloplasty, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Type of Valvuloplasty, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Type of Valvuloplasty, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Type of Valvuloplasty, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Type of Valvuloplasty, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
      • South Africa
      • North Africa
      • Central Africa

9. Competitive Landscape

  • Edwards Lifesciences Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Boston Scientific Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Medtronic plc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Braun SE
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • NuMED Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Balton Sp. z o.o.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cook Medical
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cardinal Health
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Osypka AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Braile Biomedica
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!